Gatenby, R. A. & Gillies, R. J. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891–899 (2004).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Kim, J. W., Gao, P. & Dang, C. V. Effects of hypoxia on tumor metabolism. Cancer Metastasis Rev. 26, 291–298 (2007).ArticleÂ
PubMedÂ
Google ScholarÂ
Liao, D. & Johnson, R. S. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev. 26, 281–290 (2007).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Lee, A. H., Iwakoshi, N. N. & Glimcher, L. H. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol. Cell. Biol. 23, 7448–7459 (2003).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Godet, I. et al. Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis. Nat. Commun. 10, 4862 (2019).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Semenza, G. L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721–732 (2003).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Gilkes, D. M., Semenza, G. L. & Wirtz, D. Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat. Rev. Cancer 14, 430–439 (2014).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Rapisarda, A. & Melillo, G. Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia. Nat. Rev. Clin. Oncol. 9, 378–390 (2012).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Chen, X. & Cubillos-Ruiz, J. R. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat. Rev. Cancer 21, 71–88 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Avril, T., Vauleon, E. & Chevet, E. Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers. Oncogenesis 6, e373 (2017).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Chen, S. et al. The emerging role of XBP1 in cancer. Biomed. Pharmacother. 127, 110069 (2020).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Reinke, A. W., Baek, J., Ashenberg, O. & Keating, A. E. Networks of bZIP protein–protein interactions diversified over a billion years of evolution. Science 340, 730–734 (2013).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Bersten, D. C., Sullivan, A. E., Peet, D. J. & Whitelaw, M. L. bHLH–PAS proteins in cancer. Nat. Rev. Cancer 13, 827–841 (2013).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Samanta, D., Gilkes, D. M., Chaturvedi, P., Xiang, L. & Semenza, G. L. Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells. Proc. Natl Acad. Sci. USA 111, E5429–E5438 (2014).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Lin, A. et al. The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer. Nat. Cell Biol. 18, 213–224 (2016).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Briggs, K. J. et al. Paracrine induction of HIF by glutamate in breast cancer: EglN1 senses cysteine. Cell 166, 126–139 (2016).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Zhao, N. et al. Pharmacological targeting of Myc-regulated IRE1/XBP1 pathway suppresses Myc-driven breast cancer. J. Clin. Investig. 128, 1283–1299 (2018).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Ghosh, R. et al. Allosteric inhibition of the IRE1α RNase preserves cell viability and function during endoplasmic reticulum stress. Cell 158, 534–548 (2014).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Chen, W. et al. Targeting renal cell carcinoma with a HIF-2 antagonist. Nature 539, 112–117 (2016).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Wu, D., Potluri, N., Lu, J., Kim, Y. & Rastinejad, F. Structural integration in hypoxia-inducible factors. Nature 524, 303–308 (2015).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Wu, D. et al. Bidirectional modulation of HIF-2 activity through chemical ligands. Nat. Chem. Biol. 15, 367–376 (2019).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Zhuang, J., Shang, Q., Rastinejad, F. & Wu, D. Decoding allosteric control in hypoxia-inducible factors. J. Mol. Biol. 436, 168352 (2024).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Evans, R. M. & Mangelsdorf, D. J. Nuclear receptors, RXR, and the Big Bang. Cell 157, 255–266 (2014).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Khorasanizadeh, S. & Rastinejad, F. Visualizing the architectures and interactions of nuclear receptors. Endocrinology 157, 4212–4221 (2016).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Speltz, T. E. et al. Targeting Myc with modular synthetic transcriptional repressors derived from bHLH DNA-binding domains. Nat. Biotechnol. 41, 541–551 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Talanian, R. V., McKnight, C. J. & Kim, P. S. Sequence-specific DNA binding by a short peptide dimer. Science 249, 769–771 (1990).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Kouzarides, T. & Ziff, E. Leucine zippers of Fos, Jun and GCN4 dictate dimerization specificity and thereby control DNA binding. Nature 340, 568–571 (1989).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Canne, L. E., Ferre- D’Amare, A. R., Burley, S. K. & Kent, S. B. H. Total chemical synthesis of a unique transcription factor-related protein: cMyc–MAX. J. Am. Chem. Soc. 117, 2998–3007 (1995).ArticleÂ
CASÂ
Google ScholarÂ
Metallo, S. J. & Schepartz, A. Certain bZIP peptides bind DNA sequentially as monomers and dimerize on the DNA. Nat. Struct. Biol. 4, 115–117 (1997).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Blancafort, P., Segal, D. J. & Barbas, C. F. 3rd Designing transcription factor architectures for drug discovery. Mol. Pharmacol. 66, 1361–1371 (2004).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Boga, S., Bouzada, D., Peña, D. G., Vázquez López, M. & Vázquez, M. E. Sequence-specific DNA recognition with designed peptides. Eur. J. Org. Chem. 2018, 249–261 (2018).ArticleÂ
CASÂ
Google ScholarÂ
Chen, X. et al. XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway. Nature 508, 103–107 (2014).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Schafmeister, C. E., Po, J. & Verdine, G. L. An all-hydrocarbon cross-linking system for enchancing the helicity and metabolic stability of peptides. J. Am. Chem. Soc. 122, 5891–5892 (2000).ArticleÂ
CASÂ
Google ScholarÂ
Mason, J. M., Schmitz, M. A., Muller, K. M. & Arndt, K. M. Semirational design of Jun–Fos coiled coils with increased affinity: universal implications for leucine zipper prediction and design. Proc. Natl Acad. Sci. USA 103, 8989–8994 (2006).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Chu, Q. et al. Towards understanding cell penetration by stapled peptides. MedChemComm 6, 111–119 (2015).ArticleÂ
CASÂ
Google ScholarÂ
Bird, G. H. et al. Biophysical determinants for cellular uptake of hydrocarbon-stapled peptide helices. Nat. Chem. Biol. 12, 845–852 (2016).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
LaRochelle, J. R., Cobb, G. B., Steinauer, A., Rhoades, E. & Schepartz, A. Fluorescence correlation spectroscopy reveals highly efficient cytosolic delivery of certain penta-Arg proteins and stapled peptides. J. Am. Chem. Soc. 137, 2536–2541 (2015).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Walensky, L. D. et al. Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science 305, 1466–1470 (2004).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Bernal, F., Tyler, A. F., Korsmeyer, S. J., Walensky, L. D. & Verdine, G. L. Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide. J. Am. Chem. Soc. 129, 2456–2457 (2007).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Moellering, R. E. et al. Direct inhibition of the NOTCH transcription factor complex. Nature 462, 182–188 (2009).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kong, X. D. et al. De novo development of proteolytically resistant therapeutic peptides for oral administration. Nat. Biomed. Eng. 4, 560–571 (2020).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Bird, G. H. et al. Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic. Proc. Natl Acad. Sci. USA 107, 14093–14098 (2010).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Yang, P. Y. et al. Stapled, long-acting glucagon-like peptide 2 analog with efficacy in dextran sodium sulfate induced mouse colitis models. J. Med. Chem. 61, 3218–3223 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Chang, Y. S. et al. Stapled α-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy. Proc. Natl Acad. Sci. USA 110, E3445–E3454 (2013).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Guerlavais, V. et al. Discovery of sulanemadlin (ALRN-6924), the first cell-permeating, stabilized α-helical peptide in clinical development. J. Med. Chem. 66, 9401–9417 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Wang, G. L. & Semenza, G. L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270, 1230–1237 (1995).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Ye, I. C. et al. Molecular portrait of hypoxia in breast cancer: a prognostic signature and novel HIF-regulated genes. Mol. Cancer Res 16, 1889–1901 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Bianchini, G., Balko, J. M., Mayer, I. A., Sanders, M. E. & Gianni, L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat. Rev. Clin. Oncol. 13, 674–690 (2016).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Bharti, S. K. et al. Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft. Oncotarget 9, 15326–15339 (2018).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Vaupel, P., Mayer, A. & Hockel, M. Tumor hypoxia and malignant progression. Methods Enzymol. 381, 335–354 (2004).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Cosse, J. P. & Michiels, C. Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression. Anticancer Agents Med. Chem. 8, 790–797 (2008).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Minn, A. J. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518–524 (2005).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Garralda, E. et al. Myc targeting by OMO-103 in solid tumors: a phase 1 trial. Nat. Med. 30, 762–771 (2024).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kim, Y. W., Grossmann, T. N. & Verdine, G. L. Synthesis of all-hydrocarbon stapled α-helical peptides by ring-closing olefin metathesis. Nat. Protoc. 6, 761–771 (2011).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675 (2012).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Nguyen, L. C. et al. Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses. Sci. Adv. 8, eabi6110 (2022).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Kramer, A., Green, J., Pollard, J. Jr. & Tugendreich, S. Causal analysis approaches in Ingenuity pathway analysis. Bioinformatics 30, 523–530 (2014).ArticleÂ
PubMedÂ
Google ScholarÂ
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417–425 (2015).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at https://doi.org/10.48550/arXiv.1303.3997 (2013).Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24–26 (2011).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576–589 (2010).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Ramirez, F., Dundar, F., Diehl, S., Gruning, B. A. & Manke, T. deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res. 42, W187–W191 (2014).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ